Find clinical trials for Triple Negative Breast Cancer in Roma, Lazio
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Roma, Lazio, ITA:
with unresectable locally advanced or metastatic PD-L1-positive Triple-Negative Breast Cancer (TNBC) who have not...
Phase 3
Roma, Lazio, Italy and 75 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Roma, Italy and 506 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Roma, Italy and 508 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Roma, Italy and 273 other locations
with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who car...
Phase 3
Roma, RM, Italy and 76 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Roma, Italy and 357 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Roma, Italy and 275 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib [AZD1775]) in second or third line setting in patients with Triple...
Phase 2
Roma, Italy and 140 other locations
The purpose of this study is to evaluate the safety and efficacy of BMS-986449 alone and in combination with nivolumab in participants with advanced...
Phase 1, Phase 2
Roma, Italy and 21 other locations
(MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple negative breast cancer (TNBC), ovarian cancer...
Phase 2
Roma, Italy and 87 other locations
Clinical trials
Research sites
Resources
Legal